R. Spielberger

发表

NCCN Task Force Report. prevention and management of mucositis in cancer care.

D. Brizel, L. Elting, K. Ang, 2008, Journal of the National Comprehensive Cancer Network : JNCCN.

Solid cancers after bone marrow transplantation.

A. Nademanee, J. Niland, A. Krishnan, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

dic(5;17): A recurring abnormality in malignant myeloid disorders associated with mutations of TP53

N. Zhao, P. Wang, R. Larson, 1997, Genes, chromosomes & cancer.

CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS Selective Ablation of Acute Myeloid Leukemia Using Antibody-Targeted Chemotherapy: A Phase I Study of an Anti-CD33 Calicheamicin Immunoconjugate

I. Bernstein, M. Berger, F. Appelbaum, 2017 .

Treatment of Adult Acute Myelogenous Leukemia

S. Forman, R. Spielberger, 2003 .

A long-term follow-up report on allogeneic stem cell transplantation for patients with primary refractory acute myelogenous leukemia: impact of cytogenetic characteristics on transplantation outcome.

A. Nademanee, A. Krishnan, M. Slovak, 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hairy cell leukemia 1992.

R. Spielberger, H. Golomb, 1992, Leukemia.

Outcomes of Allogeneic Hematopoietic Cell Transplantation after Salvage-Therapy with Blinatumomab in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia.

G. Marcucci, I. Aldoss, S. Forman, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic Hematopoietic Cell Transplantation for Relapsed and Refractory Philadelphia Negative B Cell ALL in the Era of Novel Salvage Therapies.

G. Marcucci, I. Aldoss, S. Forman, 2021, Transplantation and cellular therapy.

Efficacy of mycophenolate mofetil in the treatment of chronic graft-versus-host disease.

A. Nademanee, A. Krishnan, G. Somlo, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors.

A. Nademanee, J. Niland, A. Krishnan, 2000, Blood.

Palifermin reduces patient-reported mouth and throat soreness and improves patient functioning in the hematopoietic stem-cell transplantation setting.

T. Shea, A. Cesano, B. Blazar, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Anti-CD25 radioimmunotherapy with BEAM autologous hematopoietic cell transplantation conditioning in Hodgkin lymphoma

A. Nademanee, J. Bading, J. Wong, 2021, Blood advances.

Phase II Study of Yttrium-90 Ibritumomab Tiuxetan Plus High-Dose BCNU, Etoposide, Cytarabine, and Melphalan for Non-Hodgkin Lymphoma: The Role of Histology.

A. Nademanee, A. Krishnan, S. Forman, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Phase II Study of Yttrium-90 Ibritumomab Tiuxetan Plus High Dose BEAM for Non-Hodgkin Lymphoma: The Role of Histology

A. Nademanee, A. Krishnan, S. Forman, 2017 .

Sequential bortezomib, dexamethasone, and thalidomide maintenance therapy after single autologous peripheral stem cell transplantation in patients with multiple myeloma.

A. Krishnan, P. Frankel, G. Somlo, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Total Marrow Irradiation: A New Ablative Regimen as Part of Tandem Autologous Stem Cell Transplantation for Patients with Multiple Myeloma

A. Krishnan, T. Schultheiss, J. Wong, 2010, Clinical Cancer Research.

A phase 1/2 trial of high-dose yttrium-90-ibritumomab tiuxetan in combination with high-dose etoposide and cyclophosphamide followed by autologous stem cell transplantation in patients with poor-risk or relapsed non-Hodgkin lymphoma.

David D. Smith, A. Nademanee, A. Krishnan, 2005, Blood.

Results of high-dose therapy and autologous bone marrow/stem cell transplantation during remission in poor-risk intermediate- and high-grade lymphoma: international index high and high-intermediate risk group.

A. Nademanee, J. Niland, G. Somlo, 1997, Blood.

Solid C ancers A fter B one M arrow T ransplantation

A. Nademanee, J. Niland, A. Krishnan, 2001 .

Dose-escalation trial of cladribine using five daily intravenous infusions in patients with advanced hematologic malignancies.

M. Ratain, R. Larson, R. Mick, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Consolidation with Nivolumab and Brentuximab Vedotin after Autologous Hematopoietic Cell Transplantation in Patients with High-Risk Hodgkin Lymphoma

A. Nademanee, L. Kwak, Y. Nieto, 2020 .

High-dose chemo/radiotherapy and autologous bone marrow or stem cell transplantation for poor-risk advanced-stage Hodgkin's disease during first partial or complete remission.

A. Nademanee, J. Niland, A. Krishnan, 1999, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Interferon treatment for hairy cell leukemia. An update on a cohort of 69 patients treated from 1983 to 1986.

M. Ratain, R. Mick, R. Spielberger, 1992, Leukemia & lymphoma.

Hairy cell leukemia variant, a new entity of the WHO 2008.

R. Spielberger, Qin Huang, Xiaoqiong Wang, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Interleukin-2-activated autologous bone marrow and peripheral blood stem cells in the treatment of acute leukemia and lymphoma.

J. Niland, K. van Besien, G. Somlo, 1999, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Phase II trial of a transplantation regimen of yttrium-90 ibritumomab tiuxetan and high-dose chemotherapy in patients with non-Hodgkin's lymphoma.

A. Nademanee, A. Krishnan, S. Forman, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

In vivo purging with high-dose cytarabine followed by high-dose chemoradiotherapy and reinfusion of unpurged bone marrow for adult acute myelogenous leukemia in first complete remission.

J. Niland, G. Somlo, K. Margolin, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Allogeneic Bone Marrow Transplantation for BCR-ABL Positive Acute Lymphoblastic Leukemia

J. Niland, M. Amylon, M. Slovak, 2001 .

High-Dose Etoposide and Cyclophosphamide Followed by Autologous Stem Cell Transplant in Patients with Poor-Risk or Relapsed Non-Hodgkin's Lymphoma (NHL)

David D. Smith, A. Nademanee, A. Krishnan, 2017 .

Non-Hodgkins Lymphoma (NHL) by Autologous Stem Cell Transplant in Patients with Poor-Risk or Relapsed Combination with High-Dose Etoposide and Cyclophosphamide Followed A Phase I/II Trial of High-Dose Yttrium 90 ibritumomab tiuxetan in

David D. Smith, A. Nademanee, A. Krishnan, 2013 .

Ruxolitinib as Salvage Therapy for Chronic Graft-versus-Host Disease.

K. Huelsman, S. Forman, R. Spielberger, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Polymyositis as a Manifestation of Chronic Graft‐Versus‐Host Disease

A. Nademanee, J. Niland, J. Ben-Ezra, 1996, Medicine.

Total Marrow and Lymphoid Irradiation with Post-Transplant Cyclophosphamide for Patients with AML in Remission.

J. Wong, E. Radany, G. Marcucci, 2022, Transplantation and cellular therapy.

Long term outcomes of patients with Acute Myeloid Leukemia treated with myeloablative FTBI based conditioning with Tacrolimus and sirolimus based GVHD prophylaxis regimen: 6 year follow up from Single Center.

G. Marcucci, I. Aldoss, S. Forman, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

T. Slavin, G. Marcucci, I. Aldoss, 2018, Haematologica.

Brentuximab vedotin plus nivolumab after autologous haematopoietic stem-cell transplantation for adult patients with high-risk classic Hodgkin lymphoma: a multicentre, phase 2 trial.

A. Nademanee, L. Kwak, Y. Nieto, 2022, The Lancet. Haematology.

Effects of allogeneic bone marrow transplantation on recipient bone mineral density: A prospective study.

J. Niland, A. Krishnan, R. Bhatia, 2000, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Listeriosis after 2-chlorodeoxyadenosine treatment.

R. Larson, W. Stock, R. Spielberger, 1993, The New England journal of medicine.

Equivalence of 2 Effective Graft-Versus-Host Disease Prophylaxis Regimens : Results of a Pro s p e c t i ve

M. Amylon, R. Negrin, G. Long, 2000 .

Equivalence of 2 effective graft-versus-host disease prophylaxis regimens: results of a prospective double-blind randomized trial.

A. Nademanee, J. Niland, M. Amylon, 2000, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Concomitant amphotericin B therapy, granulocyte transfusions, and GM-CSF administration for disseminated infection with Fusarium in a granulocytopenic patient.

R. Larson, R. Spielberger, A. Coene, 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Impact of donor CMV status on viral infection and reconstitution of multifunction CMV-specific T cells in CMV-positive transplant recipients.

J. Zaia, Lia Thao, S. Forman, 2008, Blood.

Characterization of cytotoxic function of CMV-pp65-specific CD8+ T-lymphocytes identified by HLA tetramers in recipients and donors of stem-cell transplants

J. Zaia, S. Forman, D. Senitzer, 2002, Transplantation.

Randomized, placebo-controlled, double-blind study of a cytomegalovirus-specific monoclonal antibody (MSL-109) for prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation.

B. Storer, M. Boeckh, D. Levitt, 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Thalidomide as salvage therapy for chronic graft-versus-host disease.

J. Niland, R. Negrin, G. Somlo, 1995, Blood.

Palifermin for oral mucositis after intensive therapy for hematologic cancers

T. Shea, D. Weisdorf, B. Blazar, 2017 .

Interleukin-2 after autologous stem-cell transplantation for adult patients with acute myeloid leukemia in first complete remission.

A. Nademanee, J. Niland, A. Krishnan, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chronic oral graft-versus-host disease: induction and maintenance therapy with photobiomodulation therapy

J. Epstein, J. Raber-Durlacher, M. Hazenberg, 2020, Supportive Care in Cancer.

Increased incidence of second neoplasms in patients treated with interferon alpha 2b for hairy cell leukemia: a clinicopathologic assessment.

J. Vardiman, R. Mick, R. Spielberger, 1994, Blood.

Phase I Trial of Total Marrow and Lymphoid Irradiation Transplantation Conditioning in Patients with Relapsed/Refractory Acute Leukemia.

An Liu, T. Schultheiss, J. Wong, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Granulocyte-Macrophage-Colony Stimulating Factor in Metastatic Renal Cell Carcinoma. A Phase II Trial

M. Ratain, B. Rini, W. Stadler, 1999 .

Interleukin-2 A fter A utologous S tem-Cell T ransplantation f or Adult P atients W ith A cute M yeloid L eukemia i n F irst Complete R emission

A. Nademanee, J. Niland, A. Krishnan, 2003 .

Long-term follow-up of 23 patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with allogeneic bone marrow transplant in first complete remission

M. Amylon, M. Slovak, R. Negrin, 1999, Leukemia.

Autologous stem-cell transplantation for poor-risk and relapsed intermediate- and high-grade non-Hodgkin's lymphoma.

A. Nademanee, J. Niland, A. Krishnan, 2000, Clinical lymphoma.

Reduced-intensity allogeneic stem cell transplantation for patients whose prior autologous stem cell transplantation for hematologic malignancy failed.

A. Nademanee, A. Krishnan, G. Somlo, 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Phase-2 Trial of an Intensified Conditioning Regimen for Allogeneic Hematopoietic Cell Transplant for Poor-Risk Leukemia

A. Nademanee, J. Wong, S. Forman, 2010, Bone Marrow Transplantation.

Long-Term Follow-Up of Multiple Myeloma Patients Treated with Tandem Autologous Transplantation Following Melphalan and Upon Recovery, Total Marrow Irradiation.

P. Frankel, G. Somlo, S. Forman, 2022, Transplantation and cellular therapy.

Functional comparison of T cells recognizing cytomegalovirus pp65 and intermediate-early antigen polypeptides in hematopoietic stem-cell transplant and solid organ transplant recipients.

A. Limaye, J. Zaia, Lia Thao, 2006, The Journal of infectious diseases.

CD154 expression is associated with neutralizing antibody titer levels postinfluenza vaccination in stem cell transplant patients and healthy adults.

David D. Smith, S. Forman, D. Diamond, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

ACUTE MYELOID LEUKAEMIA FOLLOWING INTERFERON‐ALFA TREATMENT OF HAIRY CELL LEUKAEMIA

M. L. Beau, R. Larson, J. Vardiman, 1993, British journal of haematology.

Cyclosporine and mycophenolate mofetil prophylaxis with fludarabine and melphalan conditioning for unrelated donor transplantation: a prospective study of 22 patients with hematologic malignancies

M. Angelopoulou, G. Somlo, S. Forman, 2004, Bone Marrow Transplantation.

Detection of NPM/MLF1 fusion in t(3;5)-positive acute myeloid leukemia and myelodysplasia.

M. Slovak, K. Chang, D. Arber, 2003, Human pathology.

Reliability and validity of a patient self-administered daily questionnaire to assess impact of oral mucositis (OM) on pain and daily functioning in patients undergoing autologous hematopoietic stem cell transplantation (HSCT)

P. Stiff, C. Emmanouilides, W. Bensinger, 2006, Bone Marrow Transplantation.

Reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation with fludarabine and melphalan is associated with durable disease control in myelodysplastic syndrome

M. Slovak, S. Forman, R. Bhatia, 2007, Bone Marrow Transplantation.

Primary lymphoma of the liver. Report of a case with diagnosis by fine needle aspiration.

R. Spielberger, E. Balaban, S. Demian, 1993, Acta cytologica.

Simultaneous reconstitution of multiple cytomegalovirus-specific CD8+ cell populations with divergent functionality in hematopoietic stem-cell transplant recipients.

W. Haq, J. Zaia, Lia Thao, 2005, The Journal of infectious diseases.

Cytomegalovirus immune reconstitution occurs in recipients of allogeneic hematopoietic cell transplants irrespective of detectable cytomegalovirus infection.

J. Zaia, Lia Thao, S. Forman, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Reduced-intensity conditioning followed by peripheral blood stem cell transplantation for adult patients with high-risk acute lymphoblastic leukemia.

M. Slovak, S. Forman, D. Senitzer, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Predictive Factors for Early Relapse in Multiple Myeloma after Autologous Hematopoietic Stem Cell Transplant.

R. Spielberger, T. Cao, F. Sahebi, 2019, The Permanente journal.

Economic impact of palifermin on the costs of hospitalization for autologous hematopoietic stem-cell transplant: analysis of phase 3 trial results.

S. Cantor, L. Elting, Y. Shih, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Favorable impact of allogeneic stem cell transplantation in patients with therapy-related myelodysplasia regardless of TP53 mutational status

D. Weisenburger, G. Marcucci, I. Aldoss, 2017, Haematologica.

Phase 1 Dose Escalation Trial of Total Marrow and Lymphoid Irradiation (TMLI) Using Helical Tomotherapy Combined With Etoposide (VP16) and Cyclophosphamide (CY) in Patients With Refractory Acute Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation (alloHCT)

An Liu, T. Schultheiss, J. Wong, 2014 .

Hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamethasone Chemotherapy in Mantle Cell Lymphoma Patients Is Associated with Higher Rates of Hematopoietic Progenitor Cell Mobilization Failure despite Plerixafor Rescue.

A. Nademanee, I. Aldoss, S. Forman, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Esophageal achalasia secondary to mesothelioma

Edward L. Lee, R. Spielberger, W. Peterson, 1989, Digestive Diseases and Sciences.

Entrainment of Ventricular Tachycardia by Sinus Rhythm

B. Levine, M. Kremers, R. Spielberger, 1989, Pacing and clinical electrophysiology : PACE.

Long-Term Safety Outcomes in Patients with Hematological Malignancies Undergoing Autologous Hematopoietic Stem Cell Transplantation Treated with Palifermin to Prevent Oral Mucositis.

M. de Château, M. Leinonen, P. Stiff, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Reduced-Intensity Allogeneic Peripheral Blood Stem Cell Transplantation for High-Risk Acute Lymphoblastic Leukemia: A Potential Therapeutic Approach for High Risk ALL Patients Not Eligible for Full Intensity Transplantation

M. Slovak, S. Forman, R. Spielberger, 2008 .

A Comparison of Beam and Yttrium 90 Ibritumomab Tiuxetan (Zevalin®) in Addition to Beam (Z-BEAM) in Older Patients Undergoing Autologous Stem Cell Transplant (ASCT) for B-Cell Lymphomas: Impact of Radioimmunotherapy on Transplant Outcomes.

A. Nademanee, A. Krishnan, S. Forman, 2006 .

Results of a Phase II Trial of Allogeneic Hematopoietic Stem Cell Transplantation Using 90Y-Ibritumomab Tiuxetan (Zevalin) in Combination With Fludarabine and Melphalan in Patients With High-Risk B-Cell Non-Hodgkin's Lymphoma.

A. Nademanee, S. Forman, R. Spielberger, 2023, Clinical lymphoma, myeloma & leukemia.

Maintenance thalidomide following single cycle autologous peripheral blood stem cell transplant in patients with multiple myeloma

A. Krishnan, P. Frankel, G. Somlo, 2006, Bone Marrow Transplantation.

Granulocyte‐macrophage‐colony stimulating factor in metastatic renal cell carcinoma

M. Ratain, B. Rini, W. Stadler, 1998, Cancer.

Association of pre-transplant vancomycin resistant enterococcus colonization status on long-term outcomes of allogeneic-hematopoietic cell transplantation

S. Forman, A. Artz, R. Spielberger, 2022, Bone Marrow Transplantation.

Palifermin for prevention of oral mucositis in allogeneic hematopoietic stem cell transplantation: a single-institution retrospective evaluation

J. Epstein, S. Forman, R. Spielberger, 2015, Supportive Care in Cancer.

Palifermin For Prevention Of Oral Mucositis Has No Negative Effect On Long-Term Outcome In Patients With Hematological Malignancies Undergoing HSCT - Long-Term Follow-Up To 15 Years

R. Spielberger, 2013 .

Total Marrow Irradiation: A New Ablative Regimen as Part of Tandem Autologous Stem Cell Transplantation for Patients with Multiple Myeloma

A. Krishnan, T. Schultheiss, J. Wong, 2010, Clinical Cancer Research.

Tacrolimus and Sirolimus as GVHD Prophylaxis for HLA-MRD Allogeneic HCT Conditioned with 3 Regimens: Toxicity and Efficacy in 70 Patients.

A. Nademanee, S. Forman, D. Senitzer, 2006 .

Sequential bortezomib, dexamethasone, and thalidomide maintenance therapy after single autologous peripheral stem cell transplantation in patients with multiple myeloma.

A. Krishnan, P. Frankel, G. Somlo, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Bendamustine lymphodepletion is a well‐tolerated alternative to fludarabine and cyclophosphamide lymphodepletion for axicabtagene ciloleucel therapy for aggressive B‐cell lymphoma

S. Ong, R. Spielberger, J. Zain, 2023, American journal of hematology.

Hairy cell leukemia variant, a new entity of the WHO 2008.

R. Spielberger, Qin Huang, Xiaoqiong Wang, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.